IRTC · NASDAQ · STOCK
iRhythm Technologies (IRTC) Stock Analysis
$106.58
52W $100.70 – $212.00
54/100
$3.51B
-248.1
1.32
Is IRTC Bullish or Bearish?
Mixed.
Innellis AI committee rates iRhythm Technologies, Inc. (IRTC) Watch with a composite score of 54/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +6.31 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -13.69 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 25.6% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 4.25) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Revenue growing 25.6% YoY -- genuine top-line momentum — Growth
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- News sentiment is positive (+0.18 across 11 articles, 14d) — News
Bear Case
- Price-to-book of 37.4x prices in significant intangible value — Value
- ROE of only -9.0% -- cheap may mean cheap for a reason — Value
- Debt-to-equity of 4.25 adds balance-sheet risk to the value case — Value
- Price structure making lower highs and lower lows — Technical
- MACD histogram negative -- bearish momentum — Technical
- High leverage (debt-to-equity 4.25) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
54/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 74%
of 192 Healthcare peers
Value Analyst
bearish
32
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− Price-to-book of 37.4x prices in significant intangible value
Growth Analyst
bullish
83
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 25.6% YoY -- genuine top-line momentum
Technical Analyst
neutral
49
/ 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement
− Price structure making lower highs and lower lows
Risk Analyst
bearish
30
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 4.25) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
63
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.18 across 11 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 52.1 to 53.7.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
- Technical Analyst: score 41->49 (+8).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
39.9
Neutral
MACD Histogram
-0.452
Bearish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Mixed
Support
$101.30
Resistance
$129.15
Bollinger %B
0.19
Inside Bands
Price vs Moving Averages
EMA 9
$107.79
Below
EMA 21
$110.73
Below
EMA 50
$114.24
Below
EMA 200
$125.05
Below
Fundamental Analysis
Valuation
67
Growth
81
Profitability
25
Financial Health
50
Cash Flow
70
Valuation
P/E Ratio
-248.1×
P/B Ratio
18.87×
PEG Ratio
-1.03
Dividend Yield
0.00%
52W High
$212.00
52W Low
$100.70
Quality & Growth
ROE
-2916.7%
ROA
-436.8%
Gross Margin
7145.4%
Operating Margin
-116.7%
Revenue Growth YoY
—
Debt / Equity
3.91
AI Fundamental Assessment
P/E ratio of -248.1 (inexpensive relative to a 15-40x range); Price-to-book of 18.9x; PEG ratio of -1.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -29.2%; Return on assets of -4.4%; Net margin of -1.7%; Gross margin of 71.5%; Current ratio of 3.87 (healthy short-term liquidity); Debt-to-equity of 3.91; Free cash flow per share is positive (1.18); Most recent quarter beat estimates by 12988.9%; 4 consecutive earnings beats; EPS growth accelerating (-220.7% -> +265.7% QoQ); Analyst estimates falling over recent quarters
Get the Full IRTC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →